About 20 Mg Daunorubicin Hydrochloride Injection USP
Capitalise on the revered effectiveness of 20 Mg Daunorubicin Hydrochloride Injection USP, a transcendent anthracycline antibiotic engineered for superb clinical results in treating acute myeloid and lymphocytic leukaemia. This venerable formulation receives favorable reviews from medical professionals for its reliable performance. Packaged as a single vial with convenient 20 mg strength, compliance with USP ensures quality. Markdown on market expenditure and rigorous adverse drug reaction monitoring elevate hospital safety. Suitable for export, distribution, and supply across India, it stands as a hallmark in anti-neoplastic therapy.
Application Method and Site of Administration
Administered intravenously, 20 Mg Daunorubicin Hydrochloride Injection USP is to be reconstituted with sterile water, resulting in a red lyophilized powder suitable for infusion. Its application is strictly for hospital use under medical supervision, primarily targeting hematologic malignancies such as acute myeloid and lymphocytic leukaemia. The injection is odourless and provides swift systemic delivery, optimising therapeutic outcomes through direct access to the bloodstream.
Supply Ability, Export Markets, and Certifications
We offer steady supply ability of 20 Mg Daunorubicin Hydrochloride Injection USP for distributors, exporters, suppliers, and traders in India. Main export markets include regions prioritising anti-neoplastic therapies. Encompassing sale price efficiency, expenditure management, and stringent United States Pharmacopeia compliance, each batch guarantees certified safety and potency. Customers benefit from our robust distribution network and favourable export policies, catering to global oncology needs promptly.
FAQ's of 20 Mg Daunorubicin Hydrochloride Injection USP:
Q: How should 20 Mg Daunorubicin Hydrochloride Injection USP be reconstituted?
A: The vial must be reconstituted with sterile water prior to intravenous administration. Careful reconstitution ensures optimum dissolution of the red lyophilized powder for effective infusion.
Q: What indications is this injection primarily used for?
A: This product is indicated for the treatment of acute myeloid leukaemia and acute lymphocytic leukaemia, serving as a vital anti-neoplastic agent in hospital settings.
Q: When should adverse drug reaction monitoring take place?
A: Rigorous adverse drug reaction monitoring is recommended throughout the infusion process and patient management, as part of safe hospital protocols.
Q: Where is 20 Mg Daunorubicin Hydrochloride Injection USP available for supply?
A: The injection is available for distribution, export, and supply through certified channels in India, with principal exports to global oncology markets.
Q: What is the process for intravenous infusion with this product?
A: After reconstitution, the product is diluted and infused intravenously under the supervision of a qualified medical professional in a hospital setting.
Q: What is the benefit of USP compliance for this injection?
A: United States Pharmacopeia compliance guarantees quality, safety, and efficacy, assuring hospitals and clinicians of adherence to international pharmaceutical standards.